Current and historical daily PE Ratio for Endo International PLC (
) from 2018 to Jun 21 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Endo International PLC stock (LTS:0Y5F) PE ratio as of Jun 21 2024 is 0.
More Details
Endo International PLC (LTS:0Y5F) PE Ratio (TTM) Chart
Endo International PLC (LTS:0Y5F) PE Ratio (TTM) Historical Data
View and export this data going back to 2018. Start your Free Trial
Total 1272
- 1
- 2
- 3
- 4
- 5
- 6
- 15
Endo International PLC PE Ratio (TTM) Historical Data | |||
---|---|---|---|
Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
2024-06-22 | At Loss | 2024-03-11 | At Loss |
2024-05-10 | At Loss | 2024-03-08 | At Loss |
2024-05-09 | At Loss | 2024-03-07 | At Loss |
2024-05-08 | At Loss | 2024-03-06 | At Loss |
2024-05-07 | At Loss | 2024-03-05 | At Loss |
2024-05-06 | At Loss | 2024-03-04 | At Loss |
2024-05-03 | At Loss | 2024-03-01 | At Loss |
2024-05-02 | At Loss | 2024-02-29 | At Loss |
2024-05-01 | At Loss | 2024-02-28 | At Loss |
2024-04-30 | At Loss | 2024-02-27 | At Loss |
2024-04-29 | At Loss | 2024-02-26 | At Loss |
2024-04-26 | At Loss | 2024-02-23 | At Loss |
2024-04-25 | At Loss | 2024-02-22 | At Loss |
2024-04-24 | At Loss | 2024-02-21 | At Loss |
2024-04-23 | At Loss | 2024-02-20 | At Loss |
2024-04-22 | At Loss | 2024-02-19 | At Loss |
2024-04-19 | At Loss | 2024-02-16 | At Loss |
2024-04-18 | At Loss | 2024-02-15 | At Loss |
2024-04-17 | At Loss | 2024-02-14 | At Loss |
2024-04-16 | At Loss | 2024-02-13 | At Loss |
2024-04-15 | At Loss | 2024-02-12 | At Loss |
2024-04-12 | At Loss | 2024-02-09 | At Loss |
2024-04-11 | At Loss | 2024-02-08 | At Loss |
2024-04-10 | At Loss | 2024-02-07 | At Loss |
2024-04-09 | At Loss | 2024-02-06 | At Loss |
2024-04-08 | At Loss | 2024-02-05 | At Loss |
2024-04-05 | At Loss | 2024-02-02 | At Loss |
2024-04-04 | At Loss | 2024-02-01 | At Loss |
2024-04-03 | At Loss | 2024-01-31 | At Loss |
2024-04-02 | At Loss | 2024-01-30 | At Loss |
2024-04-01 | At Loss | 2024-01-29 | At Loss |
2024-03-29 | At Loss | 2024-01-26 | At Loss |
2024-03-28 | At Loss | 2024-01-25 | At Loss |
2024-03-27 | At Loss | 2024-01-24 | At Loss |
2024-03-26 | At Loss | 2024-01-23 | At Loss |
2024-03-25 | At Loss | 2024-01-22 | At Loss |
2024-03-22 | At Loss | 2024-01-19 | At Loss |
2024-03-21 | At Loss | 2024-01-18 | At Loss |
2024-03-20 | At Loss | 2024-01-17 | At Loss |
2024-03-19 | At Loss | 2024-01-16 | At Loss |
2024-03-18 | At Loss | 2024-01-15 | At Loss |
2024-03-15 | At Loss | 2024-01-12 | At Loss |
2024-03-14 | At Loss | 2024-01-11 | At Loss |
2024-03-13 | At Loss | 2024-01-10 | At Loss |
2024-03-12 | At Loss | 2024-01-09 | At Loss |
Endo International PLC (LTS:0Y5F) PE Ratio (TTM) Comparison
Company | Market Cap(Mil) | PE Ratio (TTM) |
---|
Business Description
Business Description
![Endo International PLC Endo International PLC logo](https://static.gurufocus.com/logos/0C000007FR.png?14)
Endo International PLC
NAICS : 325412
SIC : 2834
ISIN : IE00BJ3V9050
Description
Endo International PLC is a specialty pharmaceutical company with a considerable presence in pain management, urology, orthopedics, endocrinology, bariatrics, and others. It operates in four segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals, and International Pharmaceuticals. The company generates maximum revenue from the Branded Pharmaceuticals segment. Some of its products include XIAFLEX, SUPPRELIN, PERCOCET, TESTOPEL, VASOSTRICT, ADRENALIN, and APLISOL.